Global Autoimmune Disease Diagnostics Market 2021
- 시장 보고서
- ID: HL22034G
- 배달 시간: 1 영업일
- 꼬리표: Autoimmune Disease Diagnostics
설명
An autoimmune disease is a condition arising from an abnormal immune response to a functioning body part. There are around 80 different autoimmune disorders ranging in severity from mild to disabling, depending on which system of the body is under attack and to what degree. The global autoimmune disease diagnostics market is set to grow by US$ 2 10억 동안 2021-2027, 연평균 성장률로 성장 (CAGR) ~의 5.1% 예측 기간 동안, 데이터 및 분석 회사 StrategyHelix에 따르면. Growing patient awareness levels concerning autoimmune diseases, presence of favorable government initiatives, improved laboratory automation, rise in the geriatric population and growing prevalence of obesity, type 1 diabetes and other chronic diseases are expected to boost the market growth in the coming years.
이 보고서는 기간 동안 최신 시장 규모 데이터를 제공합니다. 2017-2020 그리고 예측 2027 covering key market aspects like sales value for autoimmune disease diagnostics. The global autoimmune disease diagnostics market is segmented on the basis of type, 성별, 기술, 및 지역. 유형별, it is categorized into systemic autoimmune disease diagnostics, and localized autoimmune disease diagnostics. The localized autoimmune disease diagnostics segment held the largest market share in 2020. 성별별, the autoimmune disease diagnostics market is divided into female, and male. The female segment accounted for the largest market share in 2020. Based on technology, the autoimmune disease diagnostics market is divided into enzyme-linked immunosorbent assay (ELISA), indirect immunofluorescence (IIF), immunoblot, multiplex immunoassays, 다른 사람.
The systemic autoimmune disease diagnostics market is further segmented into rheumatoid arthritis, psoriasis/psoriatic arthritis, systemic lupus erythematosus, multiple sclerosis, 다른 사람. 그 중, rheumatoid arthritis segment held the largest market share in 2020. The localized autoimmune disease diagnostics market is further segmented into inflammatory bowel disease, type 1 diabetes, thyroid, 다른 사람. 이들 중, thyroid segment held the largest market share in 2020.
The report has profiled some of the key players of the market such as Abbott Laboratories, Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, bioMerieux Inc., Bio-Rad AbD Serotec Limited, Bristol Myers Squibb (BMS), EUROIMMUN AG (퍼킨엘머 주식회사), 에프. Hoffmann-La Roche AG, Immuno Concepts Inc., INOVA Diagnostics Inc., 지멘스 헬시니어스 AG, SQI Diagnostics Inc., Thermo Fisher Scientific Inc., Trinity Biotech plc (IMMCO Diagnostics Inc).
이 보고서는 이 업계에서 활동하는 회사 및 조직에 매우 귀중한 리소스입니다.. It provides a cohesive picture of the autoimmune disease diagnostics market to help drive informed decision making for industry executives, 정책 입안자, 학생, 및 분석가.
보고 범위
유형: systemic autoimmune disease diagnostics, and localized autoimmune disease diagnostics
성별: female, and male
기술: enzyme-linked immunosorbent assay (ELISA), indirect immunofluorescence (IIF), immunoblot, multiplex immunoassays, 다른 사람
지역: 북아메리카, 아시아 태평양, 유럽, 및 기타 국가 (열)
고려한 연도: 이 보고서는 기간을 다룹니다 2017 에게 2027
이해관계자를 위한 주요 이점
Get a comprehensive picture of the global autoimmune disease diagnostics market
현지 데이터 및 분석을 기반으로 지역 전략 및 전략적 우선순위 파악
성장 분야 및 투자 동향 파악
Understand what the future of the global autoimmune disease diagnostics market looks like
경쟁 구도 및 기회의 창 식별
목차
1. 시장 정의
2. 연구 방법론
3. 시장 데이터 & 시야
3.1 시장 가치
3.2 시장 가치 예측
4. Autoimmune Disease Diagnostics Market by Type
4.1 Systemic Autoimmune Disease Diagnostics
4.2 Localized Autoimmune Disease Diagnostics
5. Autoimmune Disease Diagnostics Market by Gender
5.1 여성
5.2 남성
6. Autoimmune Disease Diagnostics Market by Technology
6.1 Enzyme-Linked Immunosorbent Assay (Elisa)
6.2 Indirect Immunofluorescence (Iif)
6.3 Immunoblot
6.4 Multiplex Immunoassays
6.5 기타
7. Autoimmune Disease Diagnostics Market by Region
7.1 북아메리카
7.2 아시아 태평양
7.3 유럽
7.4 나머지 세계 (열)
8. 회사 프로필
8.1 Abbott Laboratories
8.2 Beckman Coulter Inc. (Danaher Corporation)
8.3 벡톤, 디킨슨 앤 컴퍼니
8.4 bioMerieux, 주식회사.
8.5 Bio-Rad AbD Serotec Limited
8.6 Bristol Myers Squibb (BMS)
8.7 EUROIMMUN AG (퍼킨엘머, 주식회사)
8.8 에프. Hoffmann-La Roche AG
8.9 Immuno Concepts, 주식회사.
8.10 INOVA Diagnostics, 주식회사.
8.11 지멘스 헬시니어스 AG
8.12 SQI Diagnostics, 주식회사.
8.13 써모 피셔 사이언티픽(주).
8.14 Trinity Biotech plc (IMMCO Diagnostics Inc)
9. 부록
9.1 스트래티지헬릭스 소개
9.2 부인 성명